Epidermolysis bullosa simplex: A paradigm for disorders of tissue fragility

Journal of Clinical Investigation

Volumn 119, Issue 7, 2009, Pages 1784-1793

  Coulombe, Pierre A ^a,b   Kerns, Michelle L ^b   Fuchs, Elaine ^c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 14; CYTOKERATIN 5;

ANIMAL; COMPLICATION; EPIDERMOLYSIS BULLOSA SIMPLEX; GENETICS; GENOTYPE; HUMAN; INFLAMMATION; MOUSE; MUTATION; PHENOTYPE; PHYSIOLOGY;

ANIMALS; EPIDERMOLYSIS BULLOSA SIMPLEX; GENOTYPE; HUMANS; INFLAMMATION; KERATIN-14; KERATIN-5; MICE; MUTATION; PHENOTYPE;

EID: 68849091625     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI38177     Document Type: Review

References (125)

1. Garg, A., Levin, N.A., and Bernhard, J.D. 2008. Approach to dermatological diagnosis. In Fitzpatrick's dermatology in general medicine. 7th edition. K. Wolf, et al., editors. McGraw-Hill. New York, New York, USA. 23-39.
2. Fine, J.D., et al. 2000. Revised classification system for inherited epidermolysis bullosa: report of the Second International Consensus Meeting on diagnosis and classification of epidermolysis bullosa. J. Am. Acad. Dermatol. 42:1051-1066.
3. Marinkovich, M.P., and Bauer, E.A. 2008. Inherited epidermolysis bullosa. In Fitzpatrick's dermatology in general medicine. 7th edition. K. Wolf, et al., editors. McGraw-Hill. New York, New York, USA. 505-516.
4. Cooper, T.W., Bauer, E.A., and Briggaman, R.A. 1987. The mechanobullous diseases (epidermolysis bullosa). In Fitzpatrick's dermatology in general medicine. 3rd edition. T.B. Fitzpatrick, et al., editors. McGraw-Hill. New York, New York, USA. 610-626.
5. Coulombe, P.A., and Fuchs, E. 1993. Epidermolysis bullosa simplex. Semin. Dermatol. 12:173-190.
6. Horn, H.M., and Tidman, M. J. 2000. The clinical spectrum of epidermolysis bullosa simplex. Br. J. Dermatol. 142:468-472.
7. Fine, J.D., et al. 2008. The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB. J. Am. Acad. Dermatol. 58:931-950.
8. Omary, M.B., Coulombe, P.A., and McLean, W.H.I. 2004. Intermediate filament proteins and their associated diseases. N. Engl. J. Med. 351:2087-2100.
9. Paller, A.S. 2004. The complexities of epidermolysis bullosa "simplex". J. Invest. Dermatol. 122:vi-vii.
10. Gu, L.H., and Coulombe, P.A. 2007. Keratin function in skin epithelia: a broadening palette with surprising shades. Curr. Opin. Cell Biol. 19:13-23.
11. Szeverenyi, I., et al. 2008. The Human Intermediate Filament Database: comprehensive information on a gene family involved in many human diseases. Hum. Mutat. 29:351-360.
12. Fuchs, E., and Green, H. 1980. Changes in keratin gene expression during terminal differentiation of the keratinocyte. Cell. 19:1033-1042.
13. Fuchs, E.V., Coppock, S.M., Green, H., and Cleveland, D.W. 1981. Two distinct classes of keratin genes and their evolutionary significance. Cell. 27:75-84.
14. Fuchs, E. 1995. Keratins and the skin. Annu. Rev. Cell Dev. Biol. 11:123-153.
15. Hanukoglu, I., and Fuchs, E. 1983. The cDNA sequence of a type II cytoskeletal keratin reveals constant and variable structural domains among keratins. Cell. 33:915-924.
16. Coulombe, P.A., and Fuchs, E. 1990. Elucidating the early stages of keratin filament assembly. J. Cell Biol. 111:153-169.
17. Hatzfeld, M., and Weber, K. 1990. The coiled coil of in vitro assembled keratin filaments is a heterodimer of type I and II keratins: use of site-specific mutagenesis and recombinant protein expression. J. Cell Biol. 110:1199-1210.
18. McLean, W.H., et al. 1996. Loss of plectin causes epidermolysis bullosa with muscular dystrophy: cDNA cloning and genomic organization. Genes Dev. 10:1724-1735.
19. Gache, Y., et al. 1996. Defective expression of plectin/ HD1 in epidermolysis bullosa simplex with muscular dystrophy. J. Clin. Invest. 97:2289-2298.
20. Fontao, L., et al. 2004. Molecular consequences of deletion of the cytoplasmic domain of bullous pemphigoid 180 in a patient with predominant features of epidermolysis bullosa simplex. J. Invest. Dermatol. 122:65-72.
21. Pfendner, E., Rouan, F., and Uitto, J. 2005. Progress in epidermolysis bullosa: the phenotypic spectrum of plectin mutations. Exp. Dermatol. 14:241-249.
22. Coulombe, P.A., et al. 1991. Point mutations in human keratin 14 genes of epidermolysis bullosa simplex patients: genetic and functional analyses. Cell. 66:1301-1311.
23. Bonifas, J.M., Rothman, A.L., and Epstein, E.H., Jr. 1991. Epidermolysis bullosa simplex: evidence in two families for keratin gene abnormalities. Science. 254:1202-1205.
24. Hanukoglu, I., and Fuchs, E. 1982. The cDNA sequence of a human epidermal keratin: divergence of sequence but conservation of structure among intermediate filament proteins. Cell. 31:243-252.
25. Steinert, P.M., Rice, R.H., Roop, D.R., Trus, B.L., and Steven, A.C. 1983. Complete amino acid sequence of a mouse epidermal keratin subunit and implications for the structure of intermediate filaments. Nature. 302:794-800.
26. Albers, K., and Fuchs, E. 1987. The expression of mutant epidermal keratin cDNAs transfected in simple epithelial and squamous cell carcinoma lines. J. Cell Biol. 105:791-806.
27. Albers, K., and Fuchs, E. 1989. Expression of mutant keratin cDNAs in epithelial cells reveals possible mechanisms for initiation and assembly of intermediate filaments. J. Cell Biol. 108:1477-1493.
28. Coulombe, P.A., Chan, Y. M., Albers, K., and Fuchs, E. 1990. Deletions in epidermal keratins leading to alterations in filament organization in vivo and in intermediate filament assembly in vitro. J. Cell Biol. 111:3049-3064.
29. Wilson, A.K., Coulombe, P.A., and Fuchs, E. 1992. The roles of K5 and K14 head, tail, and R/K L L E G E domains in keratin filament assembly in vitro. J. Cell Biol. 119:401-414.
30. Vassar, R., Coulombe, P.A., Degenstein, L., Albers, K., and Fuchs, E. 1991. Mutant keratin expression in transgenic mice causes marked abnormalities resembling a human genetic skin disease. Cell. 64:365-380.
31. Coulombe, P.A., Hutton, M. E., Vassar, R., and Fuchs, E. 1991. A function for keratins and a common thread among different types of epidermolysis bullosa simplex diseases. J. Cell Biol. 115:1661-1674.
32. Haneke, E., and Anton-Lamprecht, I. 1982. Ultrastructure of blister formation in epidermolysis bullosa hereditaria: V. Epidermolysis bullosa simplex localisata type Weber-Cockayne. J. Invest. Dermatol. 78:219-223.
33. Anton-Lamprecht, I. 1983. Genetically induced abnormalities of epidermal differentiation and ultrastructure in ichthyoses and epidermolyses: pathogenesis, heterogeneity, fetal manifestation, and prenatal diagnosis. J. Invest. Dermatol. 81(1 Suppl.):149s-156s.
34. Ito, M., Okuda, C., Shimizu, N., Tazawa, T., and Sato, Y. 1991. Epidermolysis bullosa simplex (Koebner) is a keratin disorder. Ultrastructural and immunohistochemical study. Arch. Dermatol. 127:367-372.
35. Kitajima, Y., Inoue, S., and Yaoita, H. 1989. Abnormal organization of keratin intermediate filaments in cultured keratinocytes of epidermolysis bullosa simplex. Arch. Dermatol. Res. 281:5-10.
36. Fuchs, E., Esteves, R.A., and Coulombe, P.A. 1992. Transgenic mice expressing a mutant keratin 10 gene reveal the likely genetic basis for epidermolytic hyperkeratosis. Proc. Natl. Acad. Sci. U. S. A. 89:6906-6910.
37. Ishida-Yamamoto, A., et al. 1991. Epidermolysis bullosa simplex (Dowling-Meara type) is a genetic disease characterized by an abnormal keratinfilament network involving keratins K5 and K14. J. Invest. Dermatol. 97:959-968.
38. Kopan, R., and Fuchs, E. 1989. A new look into an old problem: keratins as tools to investigate determination, morphogenesis, and differentiation in skin. Genes Dev. 3:1-15.
39. Byrne, C., Tainsky, M., and Fuchs, E. 1994. Programming gene expression in developing epidermis. Development. 120:2369-2383.
40. Cheng, J., et al. 1992. The genetic basis of epidermolytic hyperkeratosis: a disorder of differentiationspecific epidermal keratin genes. Cell. 70:811-819.
41. Chipev, C.C., et al. 1992. A leucine→proline mutation in the H1 subdomain of keratin 1 causes epidermolytic hyperkeratosis. Cell. 70:821-828.
42. Rothnagel, J.A., et al. 1992. Mutations in the rod domains of keratins 1 and 10 in epidermolytic hyperkeratosis. Science. 257:1128-1130.
43. Lloyd, C., et al. 1995. The basal keratin network of stratified squamous epithelia: defining K15 function in the absence of K14. J. Cell Biol. 129:1329-1344.
44. Peters, B., Kirfel, J., Bussow, H., Vidal, M., and Magin, T.M. 2001. Complete cytolysis and neonatal lethality in keratin 5 knockout mice reveal its fundamental role in skin integrity and in epidermolysis bullosa simplex. Mol. Biol. Cell. 12:1775-1789.
45. Kerns, M.L., DePianto, D., Dinkova-Kostova, A. T., Talalay, P., and Coulombe, P. A. 2007. Reprogramming of keratin biosynthesis by sulforaphane restores skin integrity in epidermolysis bullosa simplex. Proc. Natl. Acad. Sci. U. S. A. 104:14460-14465.
46. Chan, Y., et al. 1994. A human keratin 14 "knockout": the absence of K14 leads to severe epidermolysis bullosa simplex and a function for an intermediate filament protein. Genes Dev. 8:2574-2587.
47. Jonkman, M.F., et al. 1996. Effects of keratin 14 ablation on the clinical and cellular phenotype in a kindred with recessive epidermolysis bullosa simplex. J. Invest. Dermatol. 107:764-769.
48. Paladini, R.D., and Coulombe, P.A. 1999. The functional diversity of epidermal keratins revealed by the partial rescue of the keratin 14 null phenotype by keratin 16. J. Cell Biol. 146:1185-1201.
49. Cao, T., Longley, M.A., Wang, X.J., and Roop, D.R. 2001. An inducible mouse model for epidermolysis bullosa simplex: implications for gene therapy. J. Cell Biol. 152:651-656.
50. Smith, F.J., Morley, S.M., and McLean, W.H. 2004. Novel mechanism of revertant mosaicism in Dowling-Meara epidermolysis bullosa simplex. J. Invest. Dermatol. 122:73-77.
51. Schuilenga-Hut, P.H., et al. 2002. Partial revertant mosaicism of keratin 14 in a patient with recessive epidermolysis bullosa simplex. J. Invest. Dermatol. 118:626-630.
52. Letai, A., et al. 1993. Disease severity correlates with position of keratin point mutations in patients with epidermolysis bullosa simplex. Proc. Natl. Acad. Sci. U. S. A. 90:3197-3201.
53. Chan, Y.M., Yu, Q.C., Fine, J.D., and Fuchs, E. 1993. The genetic basis of Weber-Cockayne epidermolysis bullosa simplex. Proc. Natl. Acad. Sci. U. S. A. 90:7414-7418.
54. Chan, Y.M., et al. 1994. Mutations in the non-helical linker segment L1-2 of keratin 5 in patients with Weber-Cockayne epidermolysis bullosa simplex. J. Cell Sci. 107:765-774.
55. Morley, S.M., et al. 1995. Temperature sensitivity of the keratin cytoskeleton and delayed spreading of keratinocyte lines derived from EBS patients. J. Cell Sci. 108:3463-3471.
56. Morley, S.M., et al. 2003. Generation and characterization of epidermolysis bullosa simplex cell lines: scratch assays show faster migration with disruptive keratin mutations. Br. J. Dermatol. 149:46-58.
57. Gu, L.H., and Coulombe, P.A. 2005. Defining the properties of the nonhelical tail domain in type II keratin 5: insight from a bullous disease-causing mutation. Mol. Biol. Cell. 16:1427-1438.
58. Fuchs, E., and Coulombe, P.A. 1992. Of mice and men: genetic skin diseases of keratin. Cell. 69:899-902.
59. Stephens, K., Sybert, V.P., Wijsman, E.M., Ehrlich, P., and Spencer, A. 1993. A keratin 14 mutational hot spot for epidermolysis bullosa simplex, Dowling-Meara: implications for diagnosis. J. Invest. Dermatol. 101:240-243.
60. Cooper, D.N., and Youssouffian, H. 1988. The CpG dinucleotide and human genetic diseases. Hum. Genet. 78:151-155.
61. Ma, L., Yamada, S., Wirtz, D., and Coulombe, P.A. 2001. A 'hot-spot' mutation alters the mechanical properties of keratin filament networks. Nat. Cell Biol. 3:503-506.
62. Werner, N.S., et al. 2004. Epidermolysis bullosa simplex-type mutations alter the dynamics of the keratin cytoskeleton and reveal a contribution of actin to the transport of keratin subunits. Mol. Biol. Cell. 15:990-1002.
63. Parry, D.A. 2005. Microdissection of the sequence and structure of intermediate filament chains. Adv. Protein Chem. 70:113-142.
64. Hatzfeld, M., and Weber, K. 1991. Modulation of keratin intermediate filament assembly by single amino acid exchanges in the consensus sequence at the C-terminal end of the rod domain. J. Cell Sci. 99:351-362.
65. Letai, A., Coulombe, P.A., and Fuchs, E. 1992. Do the ends justify the mean? Proline mutations at the ends of the keratin coiled-coil rod segment are more disruptive than internal mutations. J. Cell Biol. 116:1181-1195.
66. Hovnanian, A., et al. 1993. A missense mutation in the rod domain of keratin 14 associated with recessive epidermolysis bullosa simplex. Nat. Genet. 3:327-332.
67. Yamada, S., Wirtz, D., and Coulombe, P.A. 2003. The mechanical properties of simple epithelial keratins 8 and 18: discriminating between interfacial and bulk elasticities. J. Struct. Biol. 143:45-55.
68. Beil, M., et al. 2003. Sphingosylphosphorylcholine regulates keratin network architecture and viscoelastic properties of human cancer cells. Nat. Cell Biol. 5:803-811.
69. Rugg, E.L., et al. 1994. A functional "knockout" of human keratin 14. Genes Dev. 8:2563-2573.
70. Ku, N.O., and Omary, M.B. 2000. Keratins turn over by ubiquitination in a phosphorylation-modulated fashion. J. Cell Biol. 149:547-552.
71. Janig, E., Stumptner, C., Fuchsbichler, A., Denk, H., and Zatloukal, K. 2005. Interaction of stress proteins with misfolded keratins. Eur. J. Cell Biol. 84:329-339.
72. D'Alessandro, M., Russell, D., Morley, S.M., Davies, A.M., and Lane, E.B. 2002. Keratin mutations of epidermolysis bullosa simplex alter the kinetics of stress response to osmotic shock. J. Cell Sci. 115:4341-4351.
73. Liovic, M., et al. 2008. Dual-specificity phosphatases in the hypo-osmotic stress response of keratin-defective epithelial cell lines. Exp. Cell Res. 314:2066-2075.
74. Brenner, M., et al. 2001. Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease. Nat. Genet. 27:117-120.
75. Hagemann, T.L., Connor, J.X., and Messing, A. 2006. Alexander disease-associated glial fibrillary acidic protein mutations in mice induce Rosenthal fiber formation and a white matter stress response. J. Neurosci. 26:11162-11173.
76. Gu, L.H., et al. 2003. A usual frameshift and delayed termination codon mutation in keratin 5 causes a novel type of epidermolysis bullosa simplex with migratory circinate erythema. J. Invest. Dermatol. 121:482-485.
77. Yoneda, K., et al. 2004. An autocrine/paracrine loop linking keratin 14 aggregates to tumor necrosis factor {alpha}-mediated cytotoxicity in a keratinocyte model of epidermolysis bullosa simplex. J. Biol. Chem. 279:7296-7303.
78. Lu, H., et al. 2007. Induction of inflammatory cytokines by a keratin mutation and their repression by a small molecule in a mouse model for EBS. J. Invest. Dermatol. 127:2781-2789.
79. Lugassy, J., et al. 2008. KRT14 haploinsufficiency results in increased susceptibility of keratinocytes to TNF-alpha-induced apoptosis and causes Naegeli-Franceschetti-Jadassohn syndrome. J. Invest. Dermatol. 128:1517-1524.
80. Yoneda, K., et al. 2005. Tunel positive keratinocytes in keratin disease. J. Dermatol. Sci. 40:65-67.
81. Uttam, J., et al. 1996. The genetic basis of epidermolysis bullosa simplex with mottled pigmentation. Proc. Natl. Acad. Sci. U. S. A. 93:9079-9084.
82. Horiguchi, Y., et al. 2005. Clinical heterogeneity of 1649delG mutation in the tail domain of keratin 5: a Japanese family with epidermolysis bullosa simplex with mottled pigmentation. J. Invest. Dermatol. 125:83-85.
83. Harel, A., Bergman, R., Indelman, M., and Sprecher, E. 2006. Epidermolysis bullosa simplex with mottled pigmentation resulting from a recurrent mutation in KRT14. J. Invest. Dermatol. 126:1654-1657.
84. Betz, R.C., et al. 2006. Loss-of-function mutations in the keratin 5 gene lead to Dowling-Degos disease. Am. J. Hum. Genet. 78:510-519.
85. Lugassy, J., et al. 2006. Naegeli-Franceschetti-Jadassohn syndrome and dermatopathia pigmentosa reticularis: two allelic ectodermal dysplasias caused by dominant mutations in KRT14. Am. J. Hum. Genet. 79:724-730.
86. Fitch, K.R., et al. 2003. Genetics of dark skin in mice. Genes Dev. 17:214-228.
87. McGowan, K.A., Aradhya, S., Fuchs, H., de Angelis, M.H., and Barsh, G.S. 2006. A mouse keratin 1 mutation causes dark skin and epidermolytic hyperkeratosis. J. Invest. Dermatol. 126:1013-1016.
88. Van Den Bossche, K., Naeyaert, J.M., and Lambert, J. 2006. The quest for the mechanism of melanin transfer. Traffic. 7:769-778.
89. Boissy, R.E. 2003. Melanosome transfer to and translocation in the keratinocyte. Exp. Dermatol. 12(Suppl. 2):5-12.
90. Nobuhara, S., Idea, T., Miyachi, Y., and Takahashi, K. 2003. The head domain of keratin 5 binds to a dynein light chain, the cytoplasmic cargo complex, and might be involved in the distribution of keratin filaments and melanosomes [abstract]. J. Invest. Dermatol. 121:0498a.
91. Byers, H.R., Maheshwary, S., Amodeo, D.M., and Dykstra, S. G. 2003. Role of cytoplasmic dynein in perinuclear aggregation of phagocytosed melanosomes and supranuclear melanin cap formation in human keratinocytes. J. Invest. Dermatol. 121:813-820.
92. Kantheti, P., et al. 1998. Mutation in AP-3 delta in the mocha mouse links endosomal transport to storage deficiency in platelets, melanosomes, and synaptic vesicles. Neuron. 21:111-122.
93. Styers, M.L., et al. 2004. The endo-lysosomal sorting machinery interacts with the intermediate filament cytoskeleton. Mol. Biol. Cell. 15:5369-5382.
94. Styers, M.L., Kowalczyk, A.P., and Faundez, V. 2005. Intermediate filaments and vesicular membrane traffic: the odd couple's first dance? Traffic. 6:359-365.
95. Holbrook, K.A., Wapner, R., Jackson, L., and Zaeri, N. 1992. Diagnosis and prenatal diagnosis of epidermolysis bullosa herpetiformis (Dowling-Meara) in a mother, two affected children, and an affected fetus. Prenat. Diagn. 12:725-739.
96. Rugg, E.L., et al. 2000. DNA based prenatal testing for the skin blistering disorder epidermolysis bullosa simplex. Prenat. Diagn. 20:371-377.
97. Pfendner, E.G., Nakano, A., Pulkkinen, L., Christiano, A.M., and Uitto, J. 2003. Prenatal diagnosis for epidermolysis bullosa: a study of 144 consecutive pregnancies at risk. Prenat. Diagn. 23:447-456.
98. Lewin, A.S., Glazer, P.M., and Milstone, L.M. 2005. Gene therapy for autosomal dominant disorders of keratin. J. Investig. Dermatol. Symp. Proc. 10:47-61.
99. Hengge, U.R. 2008. SMaRT technology enables gene expression repair in skin gene therapy. J. Invest. Dermatol. 128:499-500.
100. Langan, S.M., and Williams, H.C. 2008. A systematic review of randomized controlled trials of treatments for inherited forms of epidermolysis bullosa. Clin. Exp. Dermatol. 34:20-25.
101. Radoja, N., et al. 2004. Thyroid hormones and gamma interferon specifically increase K15 keratin gene transcription. Mol. Cell. Biol. 24:3168-3179.
102. El Ghalbzouri, A., Jonkman, M., Kempenaar, J., and Ponec, M. 2003. Recessive epidermolysis bullosa simplex phenotype reproduced in vitro: ablation of keratin 14 is partially compensated by keratin 17. Am. J. Pathol. 163:1771-1779.
103. Zhou, Q., et al. 2003. Keratin 20 helps maintain intermediate filament organization in intestinal epithelia. Mol. Biol. Cell. 14:2959-2971.
104. Magin, T.M., et al. 2000. Supplementation of a mutant keratin by stable expression of desmin in cultured human EBS keratinocytes. J. Cell Sci. 113:4231-4239.
105. Kirfel, J., Peters, B., Grund, C., Reifenberg, K., and Magin, T.M. 2002. Ectopic expression of desmin in the epidermis of transgenic mice permits development of a normal epidermis. Differentiation. 70:56-68.
106. Coulombe, P.A., and Wong, P. 2004. Cytoplasmic intermediate filaments revealed as dynamic and multipurpose scaffolds. Nat. Cell Biol. 6:699-706.
107. Reichelt, J., and Magin, T.M. 2002. Hyperproliferation, induction of c-Myc and 14-3-3sigma, but no cell fragility in keratin-10-null mice. J. Cell Sci. 115:2639-2650.
108. McGowan, K.M., et al. 2002. Keratin 17 null mice exhibit age- and strain-dependent alopecia. Genes Dev. 16:1412-1422.
109. Tong, X., and Coulombe, P.A. 2006. Keratin 17 regulates hair follicle cycling in a TNFalpha-dependent fashion. Genes Dev. 20:1353-1364.
110. Kopan, R., and Fuchs, E. 1989. The use of retinoic acid to probe the relation between hyperproliferation-associated keratins and cell proliferation in normal and malignant epidermal cells. J. Cell Biol. 109:295-307.
111. Jiang, C.K., et al. 1993. Epidermal growth factor and transforming growth factor alpha specifically induce the activation- and hyperproliferation- associated keratins 6 and 16. Proc. Natl. Acad. Sci. U. S. A. 90:6786-6790.
112. Grachtchouk, M., et al. 2000. Basal cell carcinomas in mice overexpressing Gli2 in skin. Nat. Genet. 24:216-217.
113. Zhang, Y., Talalay, P., Cho, C.G., and Posner, G.H. 1992. A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proc. Natl. Acad. Sci. U. S. A. 89:2399-2403.
114. Zhang, Y., and Gordon, G.B. 2004. A strategy for cancer prevention: stimulation of the Nrf2-ARE signaling pathway. Mol. Cancer Ther. 3:885-893.
115. Kensler, T.W., et al. 2005. Effects of glucosinolate-rich broccoli sprouts on urinary levels of aflatoxin-DNA adducts and phanathrene tetraols in a randomized clinical trial in the He Zyuo township, Qidong, People's Republic of China. Cancer Epidemiol. Biomarkers Prev. 14:2605-2613.
116. Shapiro, T.A., et al. 2006. Safety, tolerance, and metabolism of broccoli sprout glucosinolates and isothiocyanates: a clinical phase I study. Nutr. Cancer. 55:53-62.
117. Cornblatt, B.S., et al. 2007. Preclinical and clinical evaluation of sulforaphane for chemoprevention in the breast. Carcinogenesis. 28:1485-1490.
118. Dinkova-Kostova, A.T., et al. 2007. Induction of the phase 2 response in mouse and human skin by sulforaphane-containing broccoli sprout extracts. Cancer Epidemiol. Biomarkers Prev. 16:847-851.
119. Weber, F.P. 1926. Recurrent bullous eruption on the feet in a child. Proc. R Soc. Med. 19:72-75.
120. Cockayne, E.A. 1938. Recurrent bullous eruption of the feet. Br. J. Dermatol. 50:358-366.
121. Koebner, H. 1886. Hereditare anlage zur blasendilbung (epidermolysis bullosa hereditaria). Dtsch. Med. Wochenschr. 12:21-22.
122. Dowling, G.B., and Meara, R.H. 1954. Epidermolysis bullosa resembling juvenile dermatitis herpetiformis. Br. J. Dermatol. 66:139-143.
123. Fischer, T., and Gedde-Dahl, T., Jr. 1979. Epidermolysis bullosa simplex and mottled pigmentation: a new dominant syndrome. I. Clinical and histological features. Clin. Genet. 15:228-238.
124. Dowling, G.B., and Freudenthal, W. 1938. Acanthosis nigricans. Br. J. Dermatol. 50:467-471.
125. Fransceschetti, A., and Jadassohn, W. 1954. On incontinentia pigmenti and differentiation of two syndromes appearing under the same name. Dermatologica. 108:1-28.